ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Director, DMPK Project Leader at Eli Lilly and Company - ApplyBlast

Senior Director, DMPK Project Leader

Eli Lilly and Company

3 days ago

4.0 on Glassdoor

Remote

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Director, DMPK Project Leader at Centessa Pharmaceuticals, a subsidiary of Eli Lilly, leads nonclinical pharmacokinetic, toxicokinetic, and ADME activities to support the progression of drug candidates, particularly for CNS disorders. This role involves collaborating with cross-functional teams to optimize DMPK properties, calculate safety margins, and prepare regulatory filings. The position requires expertise in DMPK sciences, PK modeling, and regulatory submissions to drive drug discovery and development strategies.

Responsibilities

Lead DMPK project activities and NDA filings for drug candidates
Calculate PK and toxicokinetic parameters to estimate safety margins
Collaborate with cross-functional teams to advance drug development

Skills

Qualifications

Ph.D. in Pharmaceutical SciencesPh.D. in Pharmacology

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.